Medtronic plc (NYSE:MDT)'s Chairman and Chief Executive Officer, Omar S. Ishrak recently stated, "We're focusing on -- primarily on tuck-in acquisitions. We've done other acquisitions, too. We've built a good track record of delivering good returns but we do have a very disciplined set of priorities. We work in areas we've got expertise in. We have minimal to no net EPS dilution. We have a clear financial value proposition. We've got a mid-teens adjusted return hurdle rate. So these are clear financial imperatives that we put in place while we do the M&A. It's highly disciplined and something that we are pretty pleased with the sort of success we're seeing, HeartWare being a recent example of great success where we've translated an inorganic activity into a high-growth organic activity through really good acquisition and integration processes."